For example, lncRNA-ATB in breast cancer promotes metastasis and tastuzumab resistance by competitively binding miR-200c sites, upregulating ZEB1 and ZNF-217, and then inducing EMT [125], and lncRNA-CTS in cervical cancer promotes metastasis and TGFβ1-induced EMT by competitive binding of miR-505 sites, consequently upregulating ZEB2 [126]. The gene discussed is ZNF217; the disease is breast cancer.